Interaction of Antihypertensive Drugs with Anti-Inflammatory Drugs

Cardiology (Switzerland)

Volumn 88, Issue , 1997, Pages 47-51

  Polónia, Jorge ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antihypertensive drugs; Blood pressure; Enalapril; Indomethacin; Nifedipine GITS; Nonsteroidal anti inflammatory drugs

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; INDOMETACIN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT;

CONFERENCE PAPER; PRIORITY JOURNAL;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; MIDDLE AGED; SAFETY; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 1842369627     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177507     Document Type: Article

References (37)

1. Abraham PA. Keane WF: Glomerular and interstitial diseases induced by nonsteroidal antiinflammatory drugs. Am J Nephrol 1984:4:1-6.
2. Durao V. Martins Prata M. Pires-Goncalvcs LM: Modification of antihypertensive effect of bcta-adrenoccptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet 1977;ii: 1005-1007.
3. Lopez-Ovejero JA. Weber MA. Drayer JIM. Sealcy JE. Laragli JH: Effects of indomethacin alone and during diuretic or beta-adreno-recep-tor blockade therapy on blood pressure and the renin system in essential hypertension. Clin Sci Mol Med 1978;55:S203 S205.
4. Salvetti A, Arzilli F, Pedrinelli R, Beggi P, Motolese A: Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. Eur J Clin Pharmacol 1982:22:197-201.
5. Moore TJ. Crantz FR, Hollcnberg NK. et al: Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension 1981;3:168-183.
6. Salvetti A, Pedrinalli R, Magagna A, Ugenli P: Differential effects of selective and non-sc-lective prostaglandin-synthesis inhibition on the pharmacological responses to captopril in patients with essential hypertension. Clin Sci 1982;63:S261-S263.
7. Silbcrbauer K. Stanek B. Tempi H: Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. Br J Clin Pharmacol 1982:14:S87-S93.
8. Watkins J. Abbott EC. Hensby CN. Webster J. Dollery CT: Attenuation of the hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J 1980;281:702-705.
9. Brown J. Dollery C, Valdes G: Interaction of nonsteroidal anti-inflammatorv drugs with antihypertensive and diuretic agents. Am J Med 1986:81 (suppl 2B):43-57.
10. Oates JA: Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs. Hypertension 1988:11 (suppl 11):114-116
11. Hardy BG, Bartlc WR, Myers M. Bailey DG. Edgar B: Effects of indomethacin on the pharmacokinetics of felodipine. Br J Clin Pharmacol 1988;26:557-567.
12. Baez MA. Alvarez CR. Weidlcr DJ: Effects of the nonsteroidal anti-inflammatory drugs, pi-roxicam or sulindac. on the antihypertensive actions of propranolol and verapamil. J Hy-pertens 1987;(suppl 5):S563-S566.
13. Moncada S. Vane JR: Pharmacology and endogenous roles of prostaglandins, endoperox-ides, thromboxane A2, and prostacyclin. Pharmacol Rev 1978;30:293-331.
14. Yun J. Kelly G. Bartter FC. Smith H Jr: Role of prostaglandins in the control of renin secretion in the dog. Circ Res 1977;50:459-464.
15. Johnson AG, Nguyen TV. Owe-Young R. Williamson DJ. Day RO: Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: The role of cndothclin-1. J Hum Hvpcrtcns 1996;10:257-261.
16. Radack K. Deck C: Do nonsteroidal antiinflammatory drugs interfere with blood pressure control in hypertensive patients? J Gen Intern Med 1987;2:108-112.
17. Pope JE, Anderson JJ. Felson DT: A metaanalysis of the effects of nonsteroidal antiinflammatory drugs on blood pressure. Arch Intern Med 1993;153:477-484.
18. Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121:289-300.
19. Sedor JR. Williams SL, Chremos AW, Johnson CL. Dunn MJ: Effects of sulindac and indo-methacin on renal prostaglandin synthesis. Clin Pharmacol Ther 1984:36:85-91.
20. Silverstein ME, Feldman RC, Henderson LW, Engelman K: Acute effects of indomcthacin and aspirin on human renal function. Clin Res 1975;23:374a.
21. Laiwah ACY, Mactier RA: Antagonistic effect of nonsteroidal anti-inflammatory drugs on fu-rosemide-induccd diuresis in cardiac failure. Br Med J 1981:283:714.
22. Wennmalm A: Influence of indomcthacin on the systemic and pulmonary vascular resistance in man. Clin Sei Mol Med 1978:54:141-145.
23. Nowak J. Wennmalm A: Influence of indomcthacin and of prostaglandin El on total and regional blood flow in man. Acta Physiol Scand 1978;102:484-491.
24. Negus P. Tannen RL, Dunn MJ: Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man. Prostaglandins 1976;12:175-180.
25. Dzau VJ. Packer M. Lilly LS, Swartz SL, Hollenberg NK, Williams GH: Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984;310:347-352.
26. Polònia J. Boaventura I. Gama G. Camòes I. Bernardo F. Andrade P. Nunes JP. Brandào F. Cerqueira-Gomes M: Influence of non-steroidal anti-inflammatory drugs on renal function and 24h-ambulatory blood pressure-reducing effects of enalapril and nifedipine-GITS in hypertensive patients. J Hypertens 1995:13:925-931.
27. Cinquegrani MP. Liang CS: Antihypertensive effects of pinacidil in patients with and without indomethacin pretreatment. Clin Exp Hypertens 1988;10:411-431.
28. Levenson DJ. Simmons CE. Brenner BM: Ara-chidonic acid metabolism, prostaglandins and the kidney. Am J Med 1982,72:354-357.
29. Beckmann ML, Gerber JG, Byyny RL, Lo-Vcrdc M. Nies AS: Propranolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension 1988;12:582-588.
30. Quilley J, Duchin KL. Hudes EM. McGiff JC: The antihypertensive effect of captopril in essential hypertension: Relationship to prostaglandins and the kallikrein-kinin system. J Hypertens 1987;5:121-128.
31. Witzgall H, Scherer B, Weber PC: Involvement of prostaglandins in the actions of captopril. Clin Sci 1982;63:265S-267S.
32. Dusing R. Scherhag R, Landsberg G, Glanzer K, Kramer HJ: The converting enzyme inhibitor captopril stimulates prostacyclin synthesis by isolated rat aorta. Eur J Pharmacol 1983;91: 501-504.
33. Schor K: Converting enzyme inhibitors and the interaction between kinins and eicosanoids. J Cardiovasc Pharmacol 1990;15(suppl 6):S60-S68.
34. Williams RL. Davies RO. Berman RS. et al: Hydrochlorothiazide pharmacokinetics and pharmacological effect: The influence of indomethacin. J Clin Pharmacol 1982:22:32-41.
35. Wong DG, Spence JD. Lamki L. Freeman D. McDonald JWD: Effects of nonsteroidal antiinflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet 1986:i: 997-1000.
36. Polònia J. Gama G. Santos A: Attenuation of the anti-hypertensive effects of enalapril by indomcthacin. Independence from renal sodium retention. Rev Port Cardiol 1996; 15:485-492.
37. Hall D, Zcitlcr H, Rudolph W: Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992; 20:1549-1555.